|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Loss on deconsolidation of subsidiaries | |||
| Loss from equity method investment | |||
| Change in fair value of warrants | |||
| Issuance costs of warrants | |||
| Depreciation and amortization | |||
| Amortization of right-of-use assets | |||
| Non-cash operating lease expense | |||
| Change in allowance of credit losses | |||
| Deferred tax (benefit) expense | |||
| Share-based compensation expenses | |||
| Changes in operating assets and liabilities: | |||
| Accounts receivable | |||
| Advances to suppliers | |||
| Prepayments and other current assets, net | |||
| Other non-current assets | |||
| Inventory | |||
| Accounts payable | |||
| Advances from customers | |||
| Taxes payable | |||
| Accruals and other liabilities | |||
| Operating lease liability | |||
| Amounts due to related parties | |||
| Net cash used in operating activities | |||
| Cash flows from investing activities | |||
| Purchases of property and equipment | |||
| Loans to third parties | |||
| Collection of loans to third parties | |||
| Proceeds from disposal of equity method investment | |||
| Purchase of equity method investment | |||
| Net cash (used in) provided by investing activities | |||
| Cash flows from financing activities | |||
| Proceeds from short-term loans | |||
| Repayments of short-term loans | |||
| Net cash provided by financing activities | |||
| Effect of foreign exchange rate on cash | |||
| Net increase in cash | |||
| Cash at the beginning of the year | |||
| Cash at the end of the year | |||
| Supplemental disclosures of cash flow information: | |||
| Interest paid | |||
| Supplemental disclosures of non-cash investing and financing transactions: | |||
| ROU assets recognized | |||
| Gain (loss) on deconsolidation of a subsidiary | |||
| Loss from equity investment | |||
| Right-of-use assets recognized | |||
| Ordinary Shares issued for deferred compensation expense | |||
| Ordinary Shares issued for deferred compensation expense– noncurrent portion | |||
| Warrant liabilities exercised under zero exercise price option |
Loading...